Core Insights - Tryg reported a strong financial performance for 2025, with an insurance service result of DKK 7,945 million, up from DKK 7,056 million in 2024, and a combined ratio of 80.3%, improved from 81.7% [1][9][10] - The company announced an ordinary dividend of DKK 8.20 per share, representing an increase of over 5% from the previous year, and initiated a DKK 1 billion share buyback program [1][9] - The solvency ratio at the end of 2025 was reported at 196%, down from 204% in Q3 2025, indicating a strong capital position [1][9] Financial Highlights - The investment result for 2025 was DKK 778 million, a decrease from DKK 911 million in 2024 [1][9] - Pre-tax profit increased to DKK 7,212 million from DKK 6,303 million in the previous year, while profit after tax rose to DKK 5,405 million from DKK 4,816 million [1][9] - The expense ratio slightly improved to 13.4% from 13.5% in 2024 [9] Customer and Strategic Developments - Customer satisfaction score improved to 82 in 2025, up from a baseline of 81 in 2024 [4] - The company is on track to meet its financial and strategic targets for 2027, focusing on profitability improvements, particularly in Norway, and expanding partnerships across Scandinavia [6] - Tryg emphasized the importance of a resilient business model to support customer needs and shareholder returns during uncertain times [6]

Core Viewpoint - Telenor has agreed to sell its 24.95% stake in True Corporation for approximately NOK 39 billion, marking a significant divestment after 25 years in Thailand [1][6]. Group 1: Transaction Details - The sale price is set at THB 11.70 per share, which represents a 36% increase from the closing price on the first trading day post-merger in March 2023, and a 4% premium to the last three months' volume-weighted average share price [7]. - Telenor will also have a mutual put/call option for the remaining 5.35% stake two years after the initial sale, priced at the higher of THB 11.70 per share or the market price at that time [1]. Group 2: Financial Implications - The proceeds from the sale of the 24.95% stake are expected to be THB 100.9 billion (approximately NOK 32.3 billion), with an additional THB 21.9 billion (approximately NOK 6.9 billion) anticipated from the option exercise [11]. - Telenor expects to recognize an accounting gain of approximately NOK 14.7 billion at the closing of the initial sale, with NOK 1.6 billion related to recycling historical currency translation differences [13]. Group 3: Strategic Context - This divestment aligns with Telenor's strategy for structural simplification and focuses on enhancing shareholder value through capital discipline and effective capital allocation [9][12]. - The sale follows Telenor's recent divestment of Telenor Pakistan, indicating a broader strategy to create structural value in Asia [8]. Group 4: Company Growth and Market Position - Telenor has established market leadership in Thailand over the past 25 years, significantly contributing to mobile connectivity for millions [4][6]. - The merger of dtac and True in 2023 created Thailand's largest telecom-tech company, positioning it for future investments in 5G, AI, and digital services [5].

Core Insights - Kalmar has signed a three-year Complete Care service agreement with Yilport Oslo Terminal, continuing a partnership that began in 2016 under Cargotec, now operating independently [1][3] - The agreement includes full maintenance responsibility for Norway's largest container port, covering maintenance management, service execution, logistics, spare parts warehousing, and 24/7 technical support [2][3] Company Commitment - Kalmar aims to drive excellence through local proximity and global expertise, emphasizing its commitment to lifetime care for Yilport Oslo's operations [3] - The partnership allows Yilport Oslo to focus on its core mission of efficient goods movement while Kalmar ensures the technical availability and safety of terminal assets [3] Executive Statements - Bjørn Engelsen, Terminal Director at Yilport Oslo, highlighted the value of Kalmar's expertise and the importance of reliability for their operations, expressing excitement for the continued partnership [4] - Bredo Steen-Gundersen, Country Director Norway at Kalmar, emphasized the agreement as a world-class service partnership that maximizes productivity through total ownership of equipment health [4] Company Overview - Kalmar, headquartered in Helsinki, Finland, operates globally in over 120 countries and employs approximately 5,200 people, with sales totaling around EUR 1.7 billion in 2024 [5]

Core Viewpoint - Axogen, Inc. has announced an upsized public offering of 4,000,000 shares of common stock priced at $31.00 per share, aiming to raise approximately $124 million before expenses [1][3]. Group 1: Offering Details - The public offering is set to close on January 23, 2026, pending customary closing conditions [2]. - Wells Fargo Securities and Mizuho are the lead book-running managers, with Canaccord Genuity and Raymond James serving as co-managers for the offering [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for early payoff and termination of a term loan facility with Oberland Capital, working capital, capital expenditures, and other general corporate purposes [3]. Group 3: Regulatory Information - The offering is made under an automatic shelf registration statement on Form S-3ASR, effective upon filing with the SEC on January 21, 2026 [4]. - A preliminary prospectus supplement and accompanying prospectus will be filed with the SEC and available for free on their website [4]. Group 4: Company Overview - Axogen focuses on the development and commercialization of technologies for peripheral nerve repair, aiming to establish nerve repair as the standard of care [6]. - The company's product portfolio includes various nerve repair solutions such as Avance® and Axoguard® products [7].

Core Viewpoint - BioAge Labs, Inc. has announced the pricing of its upsized underwritten public offering of 5,897,435 shares at $19.50 per share, aiming to raise approximately $115.0 million before expenses [1]. Group 1: Offering Details - The offering is expected to close on or about January 23, 2026, subject to customary closing conditions [1]. - BioAge has granted underwriters a 30-day option to purchase an additional 884,615 shares [1]. - Goldman Sachs & Co. LLC, Piper Sandler, and Citigroup are acting as joint book-running managers for the offering [2]. Group 2: Use of Proceeds - The net proceeds will be used to fund research, clinical and process development, and manufacturing of product candidates, including BGE-102, as well as working capital, capital expenditures, and reduction of indebtedness [3]. Group 3: Company Overview - BioAge is a clinical-stage biopharmaceutical company focused on developing therapeutic candidates for metabolic diseases by targeting human aging biology [6]. - The lead product candidate, BGE-102, is a small-molecule NLRP3 inhibitor for cardiovascular risk and retinal diseases, with a Phase 1 trial currently underway [6].

SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an upsized public offering of 22,500,000 shares of its common stock. The shares of common stock are being sold to the public at a price of $10.00 per share. All of the shares of common stock to be sold in the public offering are to be ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Reflex Advanced Materials Corp. (CSE:RFLX) (FSE:HF2) (“Reflex” or the “Company”), is pleased to announce that it intends to complete a non-brokered private placement offering of units of the Company (“Units”), at a price of C$0.175 per Unit, for aggregate gross proceeds of up to C$200,000. Each Unit will be comprised of one common share of the Compa ...

LONG BEACH, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced an update relating to the development of its Neutron rocket. As the Company pushes Neutron to the limits and beyond to qualify its systems and structures for launch, qualification testing of the Stage 1 tank overnight resulted in a rupture during a hydrostatic pressure trial. Testing failures are not uncommon during ...

HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today certain year-end tax reporting information for its 2025 distributions. The following table summarizes, for income tax purposes, the nature of distributions paid to holders of Crown Castle Common Stock, par value $.01 per share (“Common Stock”), presented on a per share basis, during the calendar year ended December 31, 2025. Stockholders are urged to consult with their personal tax advisors as to their ...

LAS VEGAS, NV, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Safeguard Acquisition Corp. (NYSE: SAC.U) (the “Company”) announced that holders of the units sold in the Company’s initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriters of their overallotment option in full, completed on December 5, 2025 (the “Offering”), may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about January 26, 2026 ...